Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in women with previous gestational diabetes mellitus
2012-001371-37Phase 4Completed
- Sponsor
- Dr. med. Tina Vilsbøll
- Start
- Jul 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide in prediabetes and type 2 diabetes mellitus (T2DM), sponsored by Dr. med. Tina Vilsbøll. Primary endpoints: Change in glucose tolerance at week 52 and Change in glucose tolerance after washout and long-term follow-up. Started Jul 2012; status: completed.
02
Drugs
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-001371-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001371-37.